Victory Capital Management Inc. cut its position in shares of Ryan Specialty Holdings Inc. (NYSE:RYAN - Free Report) by 90.1% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 67,699 shares of the company's stock after selling 613,807 shares during the quarter. Victory Capital Management Inc.'s holdings in Ryan Specialty were worth $5,001,000 at the end of the most recent reporting period.
Other large investors have also recently added to or reduced their stakes in the company. Whittier Trust Co. of Nevada Inc. lifted its stake in Ryan Specialty by 281.6% during the first quarter. Whittier Trust Co. of Nevada Inc. now owns 332 shares of the company's stock worth $25,000 after purchasing an additional 245 shares during the last quarter. Golden State Wealth Management LLC bought a new position in Ryan Specialty during the first quarter worth $35,000. Fifth Third Bancorp lifted its stake in Ryan Specialty by 202.5% during the first quarter. Fifth Third Bancorp now owns 484 shares of the company's stock worth $36,000 after purchasing an additional 324 shares during the last quarter. Kapitalo Investimentos Ltda bought a new position in Ryan Specialty during the fourth quarter worth $36,000. Finally, Mizuho Bank Ltd. bought a new position in Ryan Specialty during the fourth quarter worth $49,000. 84.82% of the stock is currently owned by institutional investors.
Ryan Specialty Stock Up 2.8%
Shares of Ryan Specialty stock opened at $66.23 on Friday. The business's fifty day moving average price is $67.31 and its two-hundred day moving average price is $68.32. The company has a debt-to-equity ratio of 3.45, a current ratio of 1.05 and a quick ratio of 1.05. The company has a market capitalization of $17.38 billion, a P/E ratio of 194.78, a PEG ratio of 1.79 and a beta of 0.66. Ryan Specialty Holdings Inc. has a 1-year low of $59.13 and a 1-year high of $77.16.
Ryan Specialty (NYSE:RYAN - Get Free Report) last announced its earnings results on Thursday, May 1st. The company reported $0.39 earnings per share for the quarter, meeting the consensus estimate of $0.39. The firm had revenue of $690.17 million for the quarter, compared to the consensus estimate of $680.80 million. Ryan Specialty had a return on equity of 47.70% and a net margin of 6.97%. The firm's revenue for the quarter was up 25.0% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.35 EPS. As a group, research analysts forecast that Ryan Specialty Holdings Inc. will post 2.29 EPS for the current year.
Ryan Specialty Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Tuesday, May 27th. Shareholders of record on Tuesday, May 13th were paid a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a yield of 0.72%. The ex-dividend date was Tuesday, May 13th. Ryan Specialty's payout ratio is currently 141.18%.
Wall Street Analyst Weigh In
Several equities analysts recently issued reports on the company. TD Cowen started coverage on Ryan Specialty in a research note on Thursday, April 10th. They set a "buy" rating and a $89.00 price objective on the stock. The Goldman Sachs Group upgraded Ryan Specialty from a "neutral" rating to a "buy" rating and boosted their price objective for the company from $74.00 to $81.00 in a research report on Tuesday, May 13th. Morgan Stanley reduced their price objective on Ryan Specialty from $80.00 to $78.00 and set an "overweight" rating for the company in a research report on Monday, July 14th. Wall Street Zen lowered Ryan Specialty from a "hold" rating to a "sell" rating in a research report on Saturday. Finally, Keefe, Bruyette & Woods reduced their price objective on Ryan Specialty from $76.00 to $75.00 and set an "outperform" rating for the company in a research report on Wednesday, April 9th. Two equities research analysts have rated the stock with a sell rating, two have issued a hold rating and eight have assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $76.00.
Read Our Latest Stock Analysis on Ryan Specialty
Insider Buying and Selling at Ryan Specialty
In other news, EVP Mark Stephen Katz sold 14,377 shares of the company's stock in a transaction on Friday, June 13th. The stock was sold at an average price of $65.84, for a total value of $946,581.68. Following the completion of the sale, the executive vice president owned 1,117 shares in the company, valued at $73,543.28. This represents a 92.79% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director David P. Bolger sold 5,000 shares of the company's stock in a transaction on Tuesday, June 3rd. The shares were sold at an average price of $70.80, for a total value of $354,000.00. Following the completion of the sale, the director owned 71,467 shares of the company's stock, valued at approximately $5,059,863.60. This trade represents a 6.54% decrease in their position. The disclosure for this sale can be found here. 52.21% of the stock is owned by insiders.
Ryan Specialty Company Profile
(
Free Report)
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
Featured Articles
Want to see what other hedge funds are holding RYAN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ryan Specialty Holdings Inc. (NYSE:RYAN - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Ryan Specialty, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.
While Ryan Specialty currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.